NEXT GEN PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NEXT GEN PHARMA
Largest movements
- Cash -€216,757
down €216,757 (-74.0%), from €292,890 to €76,134
mainly Debts after one year (-€903,571) and Deferred charges and accrued income (-€37,798)
- Debts after one year -€903,571
down €903,571 (-27.1%), from €3.3m to €2.4m
- Reserves +€611,000
new in 2025: €611,000
- Tax, wage and social debts +€72,332
up €72,332 (+373.0%), from €19,392 to €91,724
of which Taxes: +€68,842
- Taxes +€60,702
up €60,702 (+1667.8%), from €3,640 to €64,341
- Gross operating margin -€34,879
down €34,879 (-31.5%), from €110,615 to €75,736
- Financial charges -€17,715
down €17,715 (-18.8%), from €94,297 to €76,583
- Other operating charges +€2,003
up €2,003 (+229.2%), from €874 to €2,876
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,397,622 | €6,181,625 | -€215,997 | -3.4% |
| Fixed assets | 21/28 | €6,011,470 | €6,012,344 | +€874 | 0.0% |
| Tangible fixed assets | 22/27 | €11,470 | €12,344 | +€874 | +7.6% |
| Furniture and vehicles | 24 | €11,470 | €12,344 | +€874 | +7.6% |
| Financial fixed assets | 28 | €6,000,000 | €6,000,000 | = | 0.0% |
| Current assets | 29/58 | €386,152 | €169,281 | -€216,871 | -56.2% |
| Amounts receivable within one year | 40/41 | €91,060 | €53,148 | -€37,913 | -41.6% |
| Trade receivables | 40 | €64,200 | €24,370 | -€39,830 | -62.0% |
| Other amounts receivable | 41 | €26,860 | €28,777 | +€1,917 | +7.1% |
| Cash at bank and in hand | 54/58 | €292,890 | €76,134 | -€216,757 | -74.0% |
| Deferred charges and accrued income | 490/1 | €2,202 | €40,000 | +€37,798 | +1716.8% |
| Total equity and liabilities | 10/49 | €6,397,622 | €6,181,625 | -€215,997 | -3.4% |
| Equity | 10/15 | €2,574,200 | €3,185,994 | +€611,794 | +23.8% |
| Contributions | 10/11 | €1,374,000 | €1,374,000 | = | 0.0% |
| Reserves | 13 | - | €611,000 | +€611,000 | |
| Distributable reserves | 133 | - | €611,000 | +€611,000 | |
| Profit (loss) carried forward | 14 | €1,200,200 | €1,200,994 | +€794 | +0.1% |
| Amounts payable | 17/49 | €3,823,422 | €2,995,631 | -€827,791 | -21.7% |
| Amounts payable after more than one year | 17 | €3,340,286 | €2,436,714 | -€903,571 | -27.1% |
| Financial debts | 170/4 | €3,340,286 | €2,436,714 | -€903,571 | -27.1% |
| Amounts payable within one year | 42/48 | €482,087 | €558,917 | +€76,830 | +15.9% |
| Current portion of amounts payable after more than one year | 42 | €428,571 | €428,571 | = | 0.0% |
| Trade debts | 44 | €9,914 | €16,526 | +€6,612 | +66.7% |
| Suppliers | 440/4 | €9,914 | €16,526 | +€6,612 | +66.7% |
| Taxes, remuneration and social security | 45 | €19,392 | €91,724 | +€72,332 | +373.0% |
| Taxes | 450/3 | €19,232 | €88,074 | +€68,842 | +358.0% |
| Remuneration and social security | 454/9 | €160 | €3,650 | +€3,490 | +2181.3% |
| Other amounts payable | 47/48 | €24,209 | €22,095 | -€2,114 | -8.7% |
| Accrued charges and deferred income | 492/3 | €1,050 | €0 | -€1,050 | -100.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €0 | €142 | +€142 | |
| Other operating charges | 640/8 | €874 | €2,876 | +€2,003 | +229.2% |
| Gross operating margin | 9900 | €110,615 | €75,736 | -€34,879 | -31.5% |
| Operating profit (loss) | 9901 | €109,741 | €72,718 | -€37,023 | -33.7% |
| Financial income | 75/76B | €680,000 | €680,000 | = | 0.0% |
| Recurring financial income | 75 | €680,000 | €680,000 | = | 0.0% |
| Financial charges | 65/66B | €94,297 | €76,583 | -€17,715 | -18.8% |
| Recurring financial charges | 65 | €94,297 | €76,583 | -€17,715 | -18.8% |
| Profit (loss) for the period before taxes | 9903 | €695,444 | €676,136 | -€19,309 | -2.8% |
| Income taxes | 67/77 | €3,640 | €64,341 | +€60,702 | +1667.8% |
| Profit (loss) for the period | 9904 | €691,805 | €611,794 | -€80,010 | -11.6% |
| Profit (loss) for the period to be appropriated | 9905 | €691,805 | €611,794 | -€80,010 | -11.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.